A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
Lois Sechler
Advertisement
BMS Bristol-Myers Squibb Company, P.O. Box 5400, Princeton, NJ 08543-5400, USA
Articles by Lois Sechler
Advertisement
Latest Updated Articles
Risk-Based Predictive Stability–An Industry PerspectivePublished: March 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
5
